Literature DB >> 18716778

Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.

A Taran, A Ignatov, B Smith, S D Costa, J Bischoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716778     DOI: 10.1007/s00280-008-0814-7

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  7 in total

1.  Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity.

Authors:  Qi Zhao; Ting Zhang; Xue-Rong Xiao; Jian-Feng Huang; Yan Wang; Frank J Gonzalez; Fei Li
Journal:  Br J Pharmacol       Date:  2019-05-07       Impact factor: 8.739

2.  Medullary thyroid cancer and pseudocirrhosis: case report and literature review.

Authors:  B L Harry; M L Smith; J R Burton; A Dasari; S G Eckhardt; J R Diamond
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

3.  Lethal acute liver failure in a patient treated with sunitinib.

Authors:  S S Guillen; M Meijer; F E de Jongh
Journal:  BMJ Case Rep       Date:  2016-03-01

Review 4.  Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.

Authors:  Andrew X Zhu; Dan G Duda; Dushyant V Sahani; Rakesh K Jain
Journal:  Cancer J       Date:  2009 Jul-Aug       Impact factor: 3.360

Review 5.  Recent advances in anti-angiogenic therapy of cancer.

Authors:  Rajeev S Samant; Lalita A Shevde
Journal:  Oncotarget       Date:  2011-03

Review 6.  Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.

Authors:  Hana Studentova; Jindriska Volakova; Martina Spisarova; Anezka Zemankova; Kvetoslava Aiglova; Tomas Szotkowski; Bohuslav Melichar
Journal:  BMC Gastroenterol       Date:  2022-02-05       Impact factor: 3.067

Review 7.  Angiogenesis in Breast Cancer Progression, Diagnosis, and Treatment.

Authors:  Chikezie O Madu; Stephanie Wang; Chinua O Madu; Yi Lu
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.